|
1
|
El-Salhy M, Gundersen D, Hatlebakk JG and
Hausken T: Irritable Bowel Syndrome: Diagnosis, Pathogenesis &
Treatment Options. Nova Science Publishers Inc; New York, NY:
2012
|
|
2
|
Thompson WG: A world view of IBS.
Irritable Bowel Syndrome: Diagnosis and Treatment. Camilleri M and
Spiller R: Saunders; Philadelphia and London: pp. 17–26. 2002
|
|
3
|
Drossman DA, Li Z, Andruzzi E, et al: U.S.
householder survey of functional gastrointestinal disorders.
Prevalence, sociodemography, and health impact. Dig Dis Sci.
38:1569–1580. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hungin AP, Whorwell PJ, Tack J and Mearin
F: The prevalence, patterns and impact of irritable bowel syndrome:
an international survey of 40,000 subjects. Aliment Pharmacol Ther.
17:643–650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilson S, Roberts L, Roalfe A, Bridge P
and Singh S: Prevalence of irritable bowel syndrome: a community
survey. Br J Gen Pract. 54:495–502. 2004.PubMed/NCBI
|
|
6
|
Whitehead WE, Burnett CK, Cook EW III and
Taub E: Impact of irritable bowel syndrome on quality of life. Dig
Dis Sci. 41:2248–2253. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Everhart JE and Renault PF: Irritable
bowel syndrome in office-based practice in the United States.
Gastroenterology. 100:998–1005. 1991.PubMed/NCBI
|
|
8
|
Harvey RF, Salih SY and Read AE: Organic
and functional disorders in 2000 gastroenterology outpatients.
Lancet. 1:632–634. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taupenot L, Harper KL and O’Connor DT: The
chromogranin-secretogranin family. N Engl J Med. 348:1134–1149.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wiedenmann B and Huttner WB: Synaptophysin
and chromogranins/secretogranins – widespread constituents of
distinct types of neuroendocrine vesicales and new tools in tumor
diagnosis. Virchows Arch B Cell Pathol Incl Mol Pathol. 58:95–121.
1989.
|
|
11
|
El-Salhy M, Lillebø E, Reinemo A and
Salmelid L: Ghrelin in patients with irritable bowel syndrome. Int
J Mol Med. 23:703–707. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sjölund K, Ekman R and Wierup N:
Covariation of plasma ghrelin and motilin in irritable bowel
syndrome. Peptides. 31:1109–1112. 2010.PubMed/NCBI
|
|
13
|
Dizdar V, Spiller R, Singh G, Hanevik K,
Gilja OH, El-Salhy M and Hausken T: Relative importance of
abnormalities of CCK and 5-HT (serotonin) in Giardia-induced
post-infectious irritable bowel syndrome and functional dyspepsia.
Aliment Pharmacol Ther. 31:883–891. 2010.PubMed/NCBI
|
|
14
|
El-Salhy M, Vaali K, Dizdar V and Hausken
T: Abnormal small intestinal endocrine cells in patients with
irritable bowel syndrome. Dig Dis Sci. 55:3508–3513. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
El-Salhy M, Gundersen D, Ostgaard H,
Lomholt-Beck B, Hatlebakk JG and Hausken T: Low densities of
serotonin and peptide YY cells in the colon of patients with
irritable bowel syndrome. Dig Dis Sci. 57:873–878. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
El-Salhy M, Gundersen D, Hatlebakk JG and
Hausken T: Abnormal rectal endocrine cells in patients with
irritable bowel syndrome. Submitted. 2012.
|
|
17
|
El-Salhy M, Seim I, Chopin L, Gundersen D,
Hatlebakk JG and Hausken T: Irritable bowel syndrome: the role of
gut neuroendocrine peptides. Front Biosci (Elite Ed). 4:2783–2800.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Coates MD, Mahoney CR, Linden DR, Sampson
JE, Chen J, Blaszyk H, Crowell MD, Sharkey KA, Gershon MD, Mawe GM
and Moses PL: Molecular defects in mucosal serotonin content and
decreased serotonin reuptake transporter in ulcerative colitis and
irritable bowel syndrome. Gastroenterology. 126:1657–1664. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang SH, Dong L, Luo JY, Gong J, Li L, Lu
XL and Han SP: Decreased expression of serotonin in the jejenum and
increased numbers of mast cells in the terminal ileum in patients
with irritable bowel syndrome. World J Gastroenterol. 13:6041–6047.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park JH, Rhee PL, Kim G, Lee JH, Kim YH,
Kim JJ, Rhee JC and Song SY: Enteroendocrine cell counts correlated
with visceral hypersensitivity in patients with
diarrhoea-predominant irritable bowel syndrome. Neurogastroenterol
Motil. 18:539–546. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dunlop SP, Jenkins D and Spiller RC:
Distinctive clinical, psychological and histological feature of
postinfective irritable bowel syndrome. Am J Gastroenterol.
98:1578–1583. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK
and Cho SW: The alteration of enterochromaffin cell, mast cell, and
lamina propria T lymphocyte numbers in irritable bowel syndrome and
its relationship with psychological factors. J Gastroenterol
Hepatol. 23:1689–1694. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Spiller RC, Jenkins D, Thornley JP, Hebden
JM, Wright T, Skinner M and Neal KR: Increased rectal mucosal
enteroendocrine cells, T lymphocytes, and increased gut
permeability following acute Campylobacter enteritis and in
post-dysenteric irritable bowel syndrome. Gut. 47:804–811. 2000.
View Article : Google Scholar
|
|
24
|
Kim HS, Lim JH, Park H and Lee SI:
Increased immunoendocrine cells in intestinal mucosa of
postinfectious irritable bowel syndrome patients 3 years after
acute Shigella infection – an observation in small case control
study. Yonsei Med J. 51:45–51. 2010.PubMed/NCBI
|
|
25
|
Dunlop SP, Coleman NS, Blackshaw E,
Perkins AC, Singh G, Marsden CA and Spiller RC: Abnormalities of
5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin
Gastroenterol Hepatol. 3:349–357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Deftos LJ: Chromogranin A: its role in
endocrine function and as an endocrine and neuroendocrine tumor
marker. Endocr Rev. 12:181–187. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
El-Salhy M, Lomholt-Beck B and Hausken T:
Chromogranin as a tool in the diagnosis of irritable bowel
syndrome. Scand J Gastroenterol. 45:1435–1439. 2010. View Article : Google Scholar
|
|
28
|
El-Salhy M, Mazzawi T, Gundersen D and
Hausken T: Chromogranin A cell density in the rectum of patients
with irritable bowel syndrome. Mol Med Rep. 6:1223–1225.
2012.PubMed/NCBI
|
|
29
|
Longstreth GF, Thompson WG, Chey WD,
Houghton LA, Mearin F and Spiller RC: Functional bowel disorder.
Gastroenterology. 130:1480–1491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sandström O and El-Salhy M: Aging and
endocrine cells of human duodenum. Mech Ageing Dev. 108:39–48.
1999.
|
|
31
|
Sandström O and El-Salhy M: Human rectal
endocrine cells and aging. Mech Ageing Dev. 108:219–226.
1999.PubMed/NCBI
|
